InsiderTrades

Form 4 for CRSP CRISPR Therapeutics AG

Accepted 2023-05-25 00:00:00 ET · period of report 2023-05-23 · accession 0001209191-23-032250 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2023-05-25 2023-05-23 CRSP Morrow Phuong Khanh Chief Medical Off M - OptEx — +6,938 6,938 New —
D 2023-05-25 2023-05-24 CRSP Morrow Phuong Khanh Chief Medical Off F - Tax $65.91 -2,527 4,411 -36% -$166.6K
D 2023-05-25 2023-05-23 CRSP Morrow Phuong Khanh Chief Medical Off M - OptEx — +6,938 20.8K +50% —

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Shares 2023-05-23 M A 6,938 — 6,938 D — — (F1) The restriced stock units shall vest as follows: (i) one quarter of the shares shall vest on May 23, 2023, (ii) one quarter of the shares shall vest on May 23, 2024, (iii) one quarter of the shares shall vest on May 23, 2025, and (iv) one quarter of the shares shall vest on May 23, 2026. (F2) Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.
2 Common Common Shares 2023-05-24 F D 2,527 $65.91 4,411 D — —
3 Derivative Restricted Stock Units 2023-05-23 M A 6,938 — 20,812 D — · — to — 6,938 Common Shares (F2) Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. (F1) The restriced stock units shall vest as follows: (i) one quarter of the shares shall vest on May 23, 2023, (ii) one quarter of the shares shall vest on May 23, 2024, (iii) one quarter of the shares shall vest on May 23, 2025, and (iv) one quarter of the shares shall vest on May 23, 2026.